Human T-Cell lymphotropic virus type I and adult T-Cell leukaemia/lymphoma

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Adult T-cell leukaemia/lymphoma (ATLL) was first identified in Japan in 1977 [1,2]. The causative agent, the human T-lymphotropic virus type I (HTLV-I), was isolated 3 years later by Gallo's group from a patient initially diagnosed as having mycosis fungoides but subsequently reclassified as a case of ATLL[3]. Since this time, much has been discovered about the molecular pathogenesis of the disease. Despite this, treatment of ATLL remains disappointing and the prognosis of acute and lymphoma types poor. In the United Kingdom, cases of ATLL are mainly restricted to people of Afro-Caribbean descent but the disease is of general importance because ATLL has also been reported in non-endemic areas and may possibly spread into other populations via blood transfusion as blood donors in the UK are currently not screened for HTLV-I.

Author supplied keywords

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Pawson, R. (1999). Human T-Cell lymphotropic virus type I and adult T-Cell leukaemia/lymphoma. Hematology, 4(1), 11–27. https://doi.org/10.1080/10245332.1999.11746426

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Professor / Associate Prof. 2

40%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Nursing and Health Professions 2

40%

Biochemistry, Genetics and Molecular Bi... 1

20%

Save time finding and organizing research with Mendeley

Sign up for free